RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study
2018-01-01 Russo, A; Ricci, F; Magagnoli, M; Rodari, M; Morello, L; Mazza, R; Chiti, A; Castagna, L; Santoro, A; Carlo-Stella, C
Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study
2018-01-01 Russo, A; Pulsoni, A; Viviani, S; Ricci, F; Mazza, R; Magagnoli, M; Morello, L; Landi, F; Guidetti, A; Merli, M; Rodari, M; Serrao, A; Annechini, G; Nervini, A; Giordano, L; Castagna, L; Passamonti, F; Chiti, A; Corradini, P; Santoro, A; Carlo-Stella, C
BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors
2019-01-01 Clarke, J; Chu, S C; Siu, L L; Machiels, J P; Markman, B; Heinhuis, K; Millward, M; Lolkema, M; Patel, S P; de Souza, P; Curigliano, G; Santoro, A; Brown, M; Fleming, R; Veniza, H; He, C S; Rottey, S
Caregiver training for a therapeutic alliance in palliative home care.
2018-01-01 Lopane, D; Pavesi, C; Arcana, C; Bonelli, B; Ferrari, S; Lopane, D; Giuffre, S; Poggio, C; Saetta, A; Rimassa, L; Santoro, A
CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
2019-01-01 Sangro, B; Hsu, C; Kang, Yk; Kim, Ty; El-Khoueiry, A; Santoro, A; Melero, I; Kudo, M; Hou, Mm; Pena, Am; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, B; Acosta, Mr; Lim, Hy; Neely, J; Zhao, Hy; Anderson, J; Yau, T
Checkpoint inhibitor treatment before haploidentical transplantation in relapsed or refractory Hodgkin Lymphoma (HL) patients is associated with higher PFS without increased toxicities
2019-01-01 De Philippis, C; Legrande, F; Bramanti, S; de Oca, Cm; Dulery, R; Bouabdallah, R; Granada, A; Devillier, R; Mariotti, J; Sarina, B; Harbi, S; Maisano, V; Furst, S; Pagliardini, T; Weiller, Pj; Lemarie, C; Calmels, B; Chabannon, C; Carlo-Stella, C; Santoro, A; Mohty, M; Blaise, D; Castagna, L
Clinical and prognostic implications of sarcopenia in patients affected by locally advanced NSCLC.
2019-01-01 Rossi, S; Disconzi, L; Toschi, L; Finocchiaro, G; Giordano, L; Lanza, E; Lutman, Rf; Santoro, A
Clinical implications of immunohistochemical assessment of somatostatin receptor subtypes 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours.
2008-01-01 Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Destro, A; Rodari, M; Rimassa, L; Giordano, L; Roncalli, M; Santoro, A
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours
2007-01-01 Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Franchi, G; Rimassa, L; Tronconi, Mc; Roncalli, M; Santoro, A
Clinical outcomes in patients with metastatic (m plus ) melanoma treated with immune-checkpoint inhibitors (ICI) with or without radiotherapy (RT): A monocentric retrospective study
2021-01-01 Grimaudo, Ms; Tronconi, Mc; Baldaccini, D; Solferino, A; Cozzaglio, L; Borroni, R; Mancini, L; Manara, S; Mrakic-Sposta, F; Veronesi, A; Scorsetti, M; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study | 1-gen-2018 | Russo, A; Ricci, F; Magagnoli, M; Rodari, M; Morello, L; Mazza, R; Chiti, A; Castagna, L; Santoro, A; Carlo-Stella, C | |
| Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) Is an Effective Regimen for Heavily Pretreated, Relapsed/Refractory Hodgkin Lymphoma Patients: A Multicenter, Retrospective Real-World Study | 1-gen-2018 | Russo, A; Pulsoni, A; Viviani, S; Ricci, F; Mazza, R; Magagnoli, M; Morello, L; Landi, F; Guidetti, A; Merli, M; Rodari, M; Serrao, A; Annechini, G; Nervini, A; Giordano, L; Castagna, L; Passamonti, F; Chiti, A; Corradini, P; Santoro, A; Carlo-Stella, C | |
| BMS-986148, an anti-mesothelin antibody-drug conjugate (ADC), alone or in combination with nivolumab demonstrates clinical activity in patients with select advanced solid tumors | 1-gen-2019 | Clarke, J; Chu, S C; Siu, L L; Machiels, J P; Markman, B; Heinhuis, K; Millward, M; Lolkema, M; Patel, S P; de Souza, P; Curigliano, G; Santoro, A; Brown, M; Fleming, R; Veniza, H; He, C S; Rottey, S | |
| Caregiver training for a therapeutic alliance in palliative home care. | 1-gen-2018 | Lopane, D; Pavesi, C; Arcana, C; Bonelli, B; Ferrari, S; Lopane, D; Giuffre, S; Poggio, C; Saetta, A; Rimassa, L; Santoro, A | |
| CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA | 1-gen-2019 | Sangro, B; Hsu, C; Kang, Yk; Kim, Ty; El-Khoueiry, A; Santoro, A; Melero, I; Kudo, M; Hou, Mm; Pena, Am; Tovoli, F; Knox, Jj; He, Ar; El-Rayes, B; Acosta, Mr; Lim, Hy; Neely, J; Zhao, Hy; Anderson, J; Yau, T | |
| Checkpoint inhibitor treatment before haploidentical transplantation in relapsed or refractory Hodgkin Lymphoma (HL) patients is associated with higher PFS without increased toxicities | 1-gen-2019 | De Philippis, C; Legrande, F; Bramanti, S; de Oca, Cm; Dulery, R; Bouabdallah, R; Granada, A; Devillier, R; Mariotti, J; Sarina, B; Harbi, S; Maisano, V; Furst, S; Pagliardini, T; Weiller, Pj; Lemarie, C; Calmels, B; Chabannon, C; Carlo-Stella, C; Santoro, A; Mohty, M; Blaise, D; Castagna, L | |
| Clinical and prognostic implications of sarcopenia in patients affected by locally advanced NSCLC. | 1-gen-2019 | Rossi, S; Disconzi, L; Toschi, L; Finocchiaro, G; Giordano, L; Lanza, E; Lutman, Rf; Santoro, A | |
| Clinical implications of immunohistochemical assessment of somatostatin receptor subtypes 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours. | 1-gen-2008 | Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Destro, A; Rodari, M; Rimassa, L; Giordano, L; Roncalli, M; Santoro, A | |
| Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours | 1-gen-2007 | Sclafani, F; Carnaghi, C; Di Tommaso, L; Chiti, A; Franchi, G; Rimassa, L; Tronconi, Mc; Roncalli, M; Santoro, A | |
| Clinical outcomes in patients with metastatic (m plus ) melanoma treated with immune-checkpoint inhibitors (ICI) with or without radiotherapy (RT): A monocentric retrospective study | 1-gen-2021 | Grimaudo, Ms; Tronconi, Mc; Baldaccini, D; Solferino, A; Cozzaglio, L; Borroni, R; Mancini, L; Manara, S; Mrakic-Sposta, F; Veronesi, A; Scorsetti, M; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 84
- 1 Contributo su Rivista::1.5 Abst... 84
Data di pubblicazione
- 2020 - 2022 8
- 2010 - 2019 52
- 2003 - 2009 24
Rivista
- ANNALS OF ONCOLOGY 21
- JOURNAL OF CLINICAL ONCOLOGY 17
- BLOOD 6
- INTERNATIONAL JOURNAL OF RADIATIO... 4
- JOURNAL OF THORACIC ONCOLOGY 4
- BONE MARROW TRANSPLANTATION 3
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 3
- RADIOTHERAPY AND ONCOLOGY 3
- EUROPEAN JOURNAL OF NUCLEAR MEDIC... 2
- HAEMATOLOGICA 2
Keyword
- Dabrafenib 1
- Immune-mediated event 1
- Melanoma 1
- Sarcoidosis 1
- Targeted therapy 1
- Trametinib 1
Lingua
- eng 30
Accesso al fulltext
- no fulltext 80
- reserved 4